The Effects Of Midazolam And Morphine On Analgesic And Sedative Activity Of Ketamine In Rats

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 11, Issue 2, 2000, Pages 109-126

  Okulicz Kozaryn, Irena ^a   Kaminska, Ewa ^a   Szczawinska, Krystyna ^a   Mikolajczak, Przemyslaw ^a   Luczak, Jacek ^b   Kotlinska Lemieszek, Aleksandra ^b   Baczyk, Ewa ^b  

^a Department of Pharmacology ^*  (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

benzodiazepine derivative; drug interaction; NMDA antagonist; opioids; tail flick test

Indexed keywords

BENZODIAZEPINE DERIVATIVE; KETAMINE; KETANEST; MIDAZOLAM MALEATE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; LOCOMOTION; MALE; NONHUMAN; PHOTOSTIMULATION; RAT; SEDATION; TAIL FLICK TEST;

ANALGESICS; ANIMAL; ANTI-ANXIETY AGENTS, BENZODIAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; HYPNOTICS AND SEDATIVES; KETAMINE; MALE; MIDAZOLAM; MORPHINE; MOTOR ACTIVITY; RATS; RATS, WISTAR;

EID: 0033815639     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.2000.11.2.109     Document Type: Article

References (25)

1. Luczak, J, Dickenson, AH, Kotlinska-Lemieszek, A. The role of ketamine, an NMDA receptor antagonist, in the management of pain. Prog Palliative Care 1995; 3: 127–134.
2. Nichols, ML, Lopez, Y, Ossipov, MH, Bian, D, Porreca, F. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphine A(1–13) or MK-801 in a nerve-ligation model of peripheral neuropathy. Pain 1997; 69: 317–322.
3. Wiesenfeld-Hallin, Z. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes? Drugs 1998; 55: 1–4.
4. Lodge, D, Johnson, KM. Noncompetitive excitatory aminoacid receptor antagonists. Trends Pharmacol Sci 1990; 11: 81–86.
5. Sadove, MS, Shulman, M, Hatano, S, Fevold, N. Analgesic effects of ketamine administered in subdissociative doses. Anesth Analg 1971; 50: 452–457.
6. Hirota, K, Lambert, DG. Ketamine: its mechanism(s) of action and usual clinical uses. Br J Anaesth 1996; 77: 441–444.
7. Javery, KB, Ussery, TW, Steger, HG, Colclough, GW. Comparison of morphine with ketamine for postoperative analgesia. Can J Anaesth 1996; 43: 212–215.
8. Yang, CY, Wong, CS, Chang, JY, Ho, ST. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anaesth 1996; 43: 379–383.
9. Kennedy, RM, Porter, FL, Miller, JP, Jaffe, DM. Comparison of fentanyl/ midazolam with ketamine/midazolam for pediatric orthopedic emergencies. Pediatrics 1998; 102: 956–963.
10. Rabben, T, Skjelbred, P, Oye, L, Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther 1999; 289: 1060–1066
11. Hara, K, Yanagihara, N, Minami, K, Ueno, S, Toyohira, Y, Sata, T, Kawamura, M, Bruss, M, Bonisch, H, Shigematsu, A, Izumi, F. Ketamine interacts with noradrenaline transporter at a site partly overlapping the desipramine binding site. Naunyn-Schmied Arch Pharmacol 1998; 358: 328–333.
12. Klepstad, P, Maurset, A, Moberg, ER, Oye, I. Evidence of the role for NMDA receptors in pain perception. Eur J Pharmacol 1990; 187: 513–518.
13. Shimoyama, N, Shimoyama, M, Inturrisi, CE, Elliot, KJ. Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology 1996; 85: 1357–1366.
14. Pekoe, GM, Smith, DJ. The involvement of opiate and monoaminergic neuronal systems in the analgesic effects of ketamine. Pain 1982; 12: 57–73
15. White, PF, Schuttler, J, Shafer, A, Stanski, DR, Horai, Y, Trevor, AJ. Comparative pharmacology of the ketamine isomers. Studies in volunteers. Br J Anaesth 1985; 57: 197–203.
16. Delatour, P, Jaussaud, P, Courtot, D, Fau, D. Enantioselective N-demethylation of ketamine in the horse. J Vet Pharmacol Ther 1991; 14: 209–212.
17. Plesan, A, Hedman, U, Xu, XJ, Wiesenfeld-Hallin, Z. Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats. Anesth Analg 1998; 86: 825–829.
18. Mogil, JS, Kest, B, Sadowski, B, Belknap, JK. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: Influence of nociceptive assay. J Pharmacol Exp Ther 1995; 276: 532–544.
19. Luger, TJ, Hayashi, T, Weiss, CG, Hill, HF. The spinal potentiating effect and supraspinal inhibitory effect of midazolam on opioid-induced analgesia in rats. Eur J Pharmacol 1995; 275: 153–162.
20. Dambisya, YM, Lee, TL. Antinociceptive effects of ketamine-opioid combinations in the mouse tail flick test. Meth Find Exp Clin Pharmacol 1994; 16: 179–184.
21. Verma, A, Kulkarni, SK. Modulation of MK-801 response by dopaminergic agents in mice. Psychopharmacology 1992; 107: 431–436.
22. Bristow, A, Orlikowski, C. Subcutaneous ketamine analgesia; postoperative analgesia using subcutaneous infusions of ketamine and morphine. Ann R Coll Surg Engl 1989;71:64–66.
23. Edwards, ND, Fletcher, A, Cole, JR, Peacock, JE. Combined infusions of morphine and ketamine for postoperative pain in elderly patients. Anaesthesia 1993; 48: 124–127.
24. Hirota, K, Okawa, H, Appadu, BL, Grandy, DK, Devi, LA, Lambert, DG. Stereoselective interaction of ketamine with recombinant µ, ĸ and δ opioid receptors expressed in Chinese hamster ovary cells. Anethesiology 1999; 90: 174–182.
25. Palaoglu, O, Ayhan, IH. The possible role of benzodiazepine receptors in morphine analgesia. Pharmacol Biochem Behav 1986; 25: 215–217 p.